Anesthesiologist Assistant in Cary, NC Accepting Medicare

5 Anesthesiologist Assistant nurses found. Showing 1 - 5

Ms. Melanie Elaine Broadbridge, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Kildaire Farm Rd, Cary, NC 27518 Phone: 363-953-7203

Mrs. Satilla Brooke Cyphers, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Kildaire Farm Rd, Cary, NC 27518 Phone: 919-350-8000

Adam Pore, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Kildaire Farm Rd, Cary, NC 27518 Phone: 919-350-8000

Haley Anne Rawitz, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Kildaire Farm Rd, Cary, NC 27518 Phone: 919-350-8000

Chelsea Brady, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Kildaire Farm Rd, Cary, NC 27518 Phone: 919-350-8000

News Archive

One cornea can treat three persons' eye disease

A new study from India has found that one donated cornea may have the potential to treat three people with eye damage or disease.

Melbourne researchers find how MAIT cells identify and attack foreign invaders

Melbourne researchers have identified what makes a specialized immune cell, known as mucosal-associated invariant T (MAIT), cells boost their numbers and attack foreign invaders at the site of the infection.

Maternal health care crisis in the U.S.: 15.8% of women in Georgia receive delayed or no prenatal care

In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that Georgia is 50th on a maternal mortality ranking, with 20.5 deaths per 100,000 live births.

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

Read more Medical News

› Verified 6 days ago